世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Global Therapeutic Contact Lens Market By Material Type (Senofilcon, Balafilcon, Lotrafilcon, Methafilcon, Others) By Application (Drug Delivery, Corneal Healing, Pain Relief, Sealing & Protection, Others) By Distribution Channel (Hospitals & Clinics, Online, Optical Retail Stores) By Region, Competition Forecast and Opportunities, 2027


Global Therapeutic Contact Lens market stood at USD 2,830.96 Million in 2021 and is expected to grow at a CAGR of 9.38% during the forecast period to reach USD 4656.82 Million by 2027. This can be ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2022年9月1日 US$4,900
シングルユーザライセンス(印刷不可)
ライセンス・価格情報・注文方法はこちら
250 英語

 

Summary

Global Therapeutic Contact Lens market stood at USD 2,830.96 Million in 2021 and is expected to grow at a CAGR of 9.38% during the forecast period to reach USD 4656.82 Million by 2027. This can be ascribed to the rising demand for therapeutic contact lenses, which has greatly increased because of the rising incidence rate of corneal diseases. Therapeutic contact lenses are frequently used to treat various corneal and ocular conditions. The therapeutic contact lenses guard against mechanical ocular surface degradation and external environmental conditions on the cornea. Patients with corneal erosion syndrome who wear therapeutic contact lenses benefit from the promotion of re-epithelialization and a reduction in pain. In the therapeutic management of corneal and ocular surface diseases, contact lenses are crucial. Soft lenses and scleral lenses are two types of contact lenses used for therapeutic purposes. Therapeutic Contact Lens have multiple therapeutic benefits such as creating a mechanical barrier between the cornea and the outside world, hydrating the corneal epithelium, speeding up corneal wound healing, and relieving discomfort, which makes therapeutic contact lenses a mandatory medication for the ail related diseases. As a result of becoming a crucial medication in the eye-related problems, the therapeutic contact lenses market will grow during the forecast period.
Increase Spending on R&D and Stepping Up Innovation to Support Market Growth
The eye is a complex and intricate organ that is fitted with a variety of anatomical and physiological drug penetration barriers, such as the precorneal and corneal barriers, the conjunctival barriers, the blood-aqueous barrier, and the blood-retinal barrier. Ocular drug distribution to the desired target tissue is a highly difficult undertaking for doctors and scientists because of these obstacles. The research and development sector mainly focuses on new ways to treat eyes by drug delivery. Therapeutic contact lenses with embedded drug-loaded particles can be created by mixing various colloidal drug-encapsulated particles, including micelles, liposomes, microemulsions, and polymeric micro- and nanoparticles. Although polymeric particles of any size can be embedded into contact lenses, especially those in the micron range, the fundamental characteristics of contact lenses, such as their optical and physical properties, are easily influenced by larger sized particles, which is why nanoparticles are most frequently used today. Various drug-loaded nanoparticles can produce therapeutic contact lenses with polymeric nanoparticles. Drug-loaded nanoparticles can typically be included by mixing with contact lens monomers before polymerization. Drugs that are unstable in the UV or heat needed for polymerization can still be put into therapeutic contact lenses that have already undergone polymerization by soaking them in particulate solutions. Also, many researchers have concentrated on the creation of drug-eluting polymeric devices inside therapeutic contact lenses in the form of implants or films with transparent center zones to extend the release of medications and boost the drug-loading capacity without compromising the fundamental features of therapeutic contact lenses.
Rapid Technological Advancement Driving Market Growth
The market for therapeutic contact lenses will rise because of rising technological advancements in the market, throughout the forecast period. Drug delivery capabilities is one of the examples of a technological development that is greatly assisting the market expansion for therapeutic contact lenses. In today's world, where people are becoming more digital, Artificial intelligence is also used in healthcare. AI in eye care seeks to enhance clinical decision-making while also significantly reducing the burden of ocular disease and avoidable blindness. The expansion of therapeutic contact lenses may also be aided by rising demand for soft contact lenses. Throughout the forecast period, the market for therapeutic contact lenses will increase due to rising advances in these lenses.
Availability of Different Types of Therapeutic Contact Lenses
The therapeutic contact lens offers a larger variety of contact lenses than before. Using a therapeutic contact lens focusing on a particular problem has also benefitted the market as specific circumstances may mandate the selection of a specific therapeutic lens. Epithelial or stromal edema should be avoided if the therapeutic goal is to protect and heal the corneal epithelium. Hence the best option is a high-Dk silicone hydrogel lens (Balafilcon A, Lotrafilcon A) or a very thin membrane-type lens (Crofilcon). A hydrophilic lens with a low water content can be taken as option, if both surface protection and encouragement of stromal wound vascularization are objectives in therapeutic contact lens. A wise financial choice is to use a daily disposable moderate-water content lens if the patient is prone to lens loss or needs to change the therapeutic lens frequently. Thus, the availability of multiple therapeutic lenses based on the material type will fuel the growth by the availability of materials used for making therapeutic contact lens, according to the role and cost of the therapeutic contact lens market.
Government Initiatives Supporting Market Growth
Favorable government actions that promote enhanced vision care will expand the therapeutic contact lens industry. The U.S. Department of Health and Human Services and the Centers for Disease Control (CDC) is attempting to raise awareness by launching several programs like the Vision Health Initiative. The goal of the Vision Health Initiative is to support contact lens wearers' access to easy and affordable eye care. Numerous private organizations and the government and public health associations are actively promoting vision care protocols. For World Sight Day, Johnson has started a campaign called "Spotlightsight." which is committed to providing 100,000 children with access to vision screenings and 1,000 sight-restoring procedures for cataract patients. The "Changing Lives" campaign of X-Cell Specialty Contacts aims to help underprivileged patients.
Market Segmentation
The global therapeutic contact lens market is segmented based on material type, application, distribution channel. Based on material type, the market can be fragmented into Senofilcon, Balafilcon, Lotrafilcon, Methafilcon, Others (Etafilcon, Narafilcon, etc.). Based on application, the market can be divided into Drug Delivery, Corneal Healing, Pain Relief, Sealing & Protection, Others (Corneal Protection, etc.). Based on Distribution Channel, the market can be segmented Hospitals & Clinics, Online, Optical Retail Stores. Regionally, North America dominated the market in 2021, with United States being the largest market. United States therapeutic contact lens market stood at USD871.50 million in 2021 on account of widespread use of this technique across academic and research institutions in the country.
Company Profiles
Alcon, Inc., CooperVision, Inc., Johnson & Johnson, Bausch, Health Companies, Inc., EssilorLuxottica S.A, Carl Zeiss Meditec AG, SynergEyes Inc., X-Cel Specialty Contacts, Hoya Corporation, SEED Co., Ltd. are among the major market players operating in the global therapeutic contact lens market.
Report Scope:
In this report, global therapeutic contact lens market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Therapeutic Contact Lens Market, By Material Type:
o Senofilcon
o Balafilcon
o Lotrafilcon
o Methafilcon
o Others
• Therapeutic Contact Lens Market, By Application:
o Drug Delivery
o Corneal Healing
o Pain Relief
o Sealing & Protection
o Others
• Therapeutic Contact Lens Market, By Distribution Channel:
o Hospitals & Clinics
o Online
o Optical Retail Stores
• Therapeutic Contact Lens Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 United Kingdom
 France
 Russia
 Germany
 Italy
o Asia-Pacific
 Japan
 China
 Australia
 India
 South Korea
 Vietnam
 Indonesia
o South America
 Brazil
 Argentina
 Colombia
 Chile
o Middle East & Africa
 Turkey
 Egypt
 Saudi Arabia
 South Africa
 Iran
 UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global therapeutic contact lens market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る


Table of Contents

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Therapeutic Contact Lens Market
5. Voice of Customer
5.1. Factors Influencing Purchase Decision
5.2. Sources of Information
5.3. Preference Based on Gender
5.4. Brand Awareness
5.5. Reasons for Using Therapeutic Contact Lens
5.6. Barriers to Adoption of Therapeutic Contact Lens
5.7. Preferred Point of Purchase
5.8. Frequency of Therapeutic Contact Lens Usage
6. Clinical Trials Analysis
6.1. Ongoing Clinical Trials
6.2. Completed Clinical Trials
6.3. Terminated Clinical Trials
7. Patent Analysis
7.1. Patent Granted (2017-2021)
7.2. Patent Applications Filed
7.3. By Material Type
8. Global Therapeutics Contact Lens Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Material Type (Senofilcon, Balafilcon, Lotrafilcon, Methafilcon, Others)
8.2.2. By Application (Drug Delivery, Corneal Healing, Pain Relief, Sealing & Protection, Others)
8.2.3. By Distribution Channel (Hospitals & Clinics, Online, Optical Retail Stores)
8.2.4. By Region
8.2.5. By Company (2021)
8.3. Market Map
9. North America Therapeutics Contact Lens Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Material Type
9.2.2. By Application
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. North America: Country Analysis
9.3.1. United States Therapeutics Contact Lens Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Material Type
9.3.1.2.2. By Application
9.3.1.2.3. By Distribution Channel
9.3.2. Canada Therapeutics Contact Lens Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Material Type
9.3.2.2.2. By Application
9.3.2.2.3. By Distribution Channel
9.3.3. Mexico Therapeutics Contact Lens Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Material Type
9.3.3.2.2. By Application
9.3.3.2.3. By Distribution Channel
10. Europe Therapeutics Contact Lens Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Material Type
10.2.2. By Application
10.2.3. By Distribution Channel
10.2.4. By Country
10.3. Europe: Country Analysis
10.3.1. United Kingdom Therapeutics Contact Lens Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Material Type
10.3.1.2.2. By Application
10.3.1.2.3. By Distribution Channel
10.3.2. France Therapeutics Contact Lens Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Material Type
10.3.2.2.2. By Application
10.3.2.2.3. By Distribution Channel
10.3.3. Russia Therapeutics Contact Lens Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Material Type
10.3.3.2.2. By Application
10.3.3.2.3. By Distribution Channel
10.3.4. Germany Therapeutic Contact Lens Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Material Type
10.3.4.2.2. By Application
10.3.4.2.3. By Distribution Channel
10.3.5. Italy Therapeutic Contact Lens Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Material Type
10.3.5.2.2. By Application
10.3.5.2.3. By Distribution Channel
11. Asia Pacific Therapeutics Contact Lens Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Material Type
11.2.2. By Application
11.2.3. By Distribution Channel
11.2.4. By Country
11.3. Asia Pacific: Country Analysis
11.3.1. Japan Therapeutics Contact Lens Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Material Type
11.3.1.2.2. By Application
11.3.1.2.3. By Distribution Channel
11.3.2. China Therapeutic Contact Lens Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Material Type
11.3.2.2.2. By Application
11.3.2.2.3. By Distribution Channel
11.3.3. Australia Therapeutic Contact Lens Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Material Type
11.3.3.2.2. By Application
11.3.3.2.3. By Distribution Channel
11.3.4. India Therapeutics Contact Lens Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Material Type
11.3.4.2.2. By Application
11.3.4.2.3. By Distribution Channel
11.3.5. South Korea Therapeutics Contact Lens Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Material Type
11.3.5.2.2. By Application
11.3.5.2.3. By Distribution Channel
11.3.6. Vietnam Therapeutics Contact Lens Market Outlook
11.3.6.1. Market Size & Forecast
11.3.6.1.1. By Value
11.3.6.2. Market Share & Forecast
11.3.6.2.1. By Material Type
11.3.6.2.2. By Application
11.3.6.2.3. By Distribution Channel
11.3.7. Indonesia Therapeutics Contact Lens Market Outlook
11.3.7.1. Market Size & Forecast
11.3.7.1.1. By Value
11.3.7.2. Market Share & Forecast
11.3.7.2.1. By Material Type
11.3.7.2.2. By Application
11.3.7.2.3. By Distribution Channel
12. South America Therapeutics Contact Lens Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Material Type
12.2.2. By Application
12.2.3. By Distribution Channel
12.2.4. By Country
12.3. South America: Country Analysis
12.3.1. Brazil Therapeutic Contact Lens Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Material Type
12.3.1.2.2. By Application
12.3.1.2.3. By Distribution Channel
12.3.2. Argentina Therapeutic Contact Lens Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Material Type
12.3.2.2.2. By Application
12.3.2.2.3. By Distribution Channel
12.3.3. Colombia Therapeutic Contact Lens Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Material Type
12.3.3.2.2. By Application
12.3.3.2.3. By Distribution Channel
12.3.4. Chile Therapeutics Contact Lens Market Outlook
12.3.4.1. Market Size & Forecast
12.3.4.1.1. By Value
12.3.4.2. Market Share & Forecast
12.3.4.2.1. By Material Type
12.3.4.2.2. By Application
12.3.4.2.3. By Distribution Channel
13. Middle East and Africa Therapeutics Contact Lens Market Outlook
13.1. Market Size & Forecast
13.1.1. By Value
13.2. Market Share & Forecast
13.2.1. By Material Type
13.2.2. By Application
13.2.3. By Distribution Channel
13.2.4. By Country
13.3. South Africa: Country Analysis
13.3.1. Turkey Therapeutic Contact Lens Market Outlook
13.3.1.1. Market Size & Forecast
13.3.1.1.1. By Value
13.3.1.2. Market Share & Forecast
13.3.1.2.1. By Material Type
13.3.1.2.2. By Application
13.3.1.2.3. By Distribution Channel
13.3.2. Egypt Therapeutic Contact Lens Market Outlook
13.3.2.1. Market Size & Forecast
13.3.2.1.1. By Value
13.3.2.2. Market Share & Forecast
13.3.2.2.1. By Material Type
13.3.2.2.2. By Application
13.3.2.2.3. By Distribution Channel
13.3.3. Saudi Arabia Therapeutic Contact Lens Market Outlook
13.3.3.1. Market Size & Forecast
13.3.3.1.1. By Value
13.3.3.2. Market Share & Forecast
13.3.3.2.1. By Material Type
13.3.3.2.2. By Application
13.3.3.2.3. By Distribution Channel
13.3.4. South Africa Therapeutics Contact Lens Market Outlook
13.3.4.1. Market Size & Forecast
13.3.4.1.1. By Value
13.3.4.2. Market Share & Forecast
13.3.4.2.1. By Material Type
13.3.4.2.2. By Application
13.3.4.2.3. By Distribution Channel
13.3.5. Iran Therapeutic Contact Lens Market Outlook
13.3.5.1. Market Size & Forecast
13.3.5.1.1. By Value
13.3.5.2. Market Share & Forecast
13.3.5.2.1. By Material Type
13.3.5.2.2. By Application
13.3.5.2.3. By Distribution Channel
13.3.6. UAE Therapeutics Contact Lens Market Outlook
13.3.6.1. Market Size & Forecast
13.3.6.1.1. By Value
13.3.6.2. Market Share & Forecast
13.3.6.2.1. By Material Type
13.3.6.2.2. By Application
13.3.6.2.3. By Distribution Channel
14. Market Dynamics
14.1. Drivers
14.2. Challenges
15. Market Trends & Developments
16. Competitive Landscape
16.1. Competition Outlook
16.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
16.2.1. Alcon, Inc.
16.2.2. CooperVision, Inc.
16.2.3. Johnson & Johnson
16.2.4. Bausch Health Companies, Inc.,
16.2.5. EssilorLuxottica S.A
16.2.6. Carl Zeiss Meditec AG
16.2.7. SynergEyes Inc.
16.2.8. X-Cel Specialty Contacts
16.2.9. Hoya Corporation
16.2.10. SEED Co., Ltd
17. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

TechSci Research 社の最新刊レポート

本レポートと同じKEY WORD(application drug)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/05 10:26

162.17 円

175.82 円

209.73 円

ページTOPに戻る